Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06071884 · ClinicalTrials.gov registry record · NA
Bridge Device for Surgical Pain for Rotator Cuff Surgery
A NA study of Pain and Rotator Cuff Injuries, sponsored by Steven Orebaugh.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT06071884: Completed NA study of Pain and Rotator Cuff Injuries, sponsored by Steven Orebaugh.
NCT06071884 is a NA study of Pain and Rotator Cuff Injuries that has completed, run by Steven Orebaugh. The registered enrollment target is 42 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06071884, a NA study of Pain and Rotator Cuff Injuries, has completed, sponsored by Steven Orebaugh.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation.
Primary Outcome
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Conditions Studied
Interventions
- DEVICE Bridge Percutaneous Nerve Field Stimulator
Study Locations (1)
Pennsylvania
- UPMC Outpatient Center - West Mifflin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2024-07-29 |
| Est. Completion | 2024-09-26 |
| Phase | NA |
What the finished NCT06071884 record still lists
NCT06071884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Bridge Percutaneous Nerve Field Stimulator is the first listed.
NCT06071884 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06071884 about?
NCT06071884 is a clinical study titled "Bridge Device for Surgical Pain for Rotator Cuff Surgery". The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation.
What is the current status of trial NCT06071884?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2024-07-29. Estimated completion is 2024-09-26.
What conditions does trial NCT06071884 study?
This clinical trial studies the following conditions: Pain, Rotator Cuff Injuries.
What interventions are being tested in trial NCT06071884?
The interventions under investigation include: Bridge Percutaneous Nerve Field Stimulator (DEVICE).
Who is sponsoring clinical trial NCT06071884?
This trial is sponsored by Steven Orebaugh, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06071884 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06071884's enrollment target sits among peer trials
42 278th of 374 higher than 96 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI